The Oncology Institute, Inc. TOI Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s operating cash flow?
- The Oncology Institute, Inc. (TOI) reported operating cash flow of -$2.22M in Q1 2026.
- How has The Oncology Institute, Inc.'s operating cash flow changed year-over-year?
- The Oncology Institute, Inc.'s operating cash flow increased by 55.6% year-over-year, from -$4.99M to -$2.22M.
- What is the long-term trend for The Oncology Institute, Inc.'s operating cash flow?
- Over 3 years (2021 to 2024), The Oncology Institute, Inc.'s operating cash flow has grown at a -5.5% compound annual growth rate (CAGR), from -$32.68M to -$27.54M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.